{"id":85393,"date":"2023-06-07T13:25:31","date_gmt":"2023-06-07T11:25:31","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/?p=85393"},"modified":"2025-10-13T15:03:51","modified_gmt":"2025-10-13T13:03:51","slug":"mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/","title":{"rendered":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio"},"content":{"rendered":"<p><strong><span class=\"TextRun SCXW213178831 BCX8\" lang=\"ES-ES\" xml:lang=\"ES-ES\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213178831 BCX8\"><a href=\"https:\/\/www.mimark.es\/\"><span data-contrast=\"none\">MiMARK Diagnostics<\/span><\/a><span data-contrast=\"auto\">, spin-off del <\/span><a href=\"https:\/\/vhir.vallhebron.com\/ca\"><span data-contrast=\"none\">Vall d\u2019Hebron Instituto de Investigaci\u00f3n (VHIR)<\/span><\/a><span data-contrast=\"auto\"> especializada en el desarrollo de soluciones innovadoras para el diagn\u00f3stico ginecol\u00f3gico con sede en el Parque Cient\u00edfico de Barcelona, ha captado 1 M\u20ac que le permitir\u00e1n acelerar el desarrollo de su test de diagn\u00f3stico <\/span><i><span data-contrast=\"auto\">in vitro<\/span><\/i><span data-contrast=\"auto\"> para el c\u00e1ncer de endometrio. La operaci\u00f3n ha sido liderada por los fondos de capital riesgo Clave Capital, Nara Capital y Namarel Ventures, y tambi\u00e9n ha participado la red de \u2018Business Angels\u2019 WA4Steam.\u00a0<\/span><\/span><\/span><\/strong><\/p>\n<p>\u201cEsta inversi\u00f3n marca el inicio de una nueva etapa para la compa\u00f1\u00eda, con nuevos retos y desaf\u00edos, y nos acompa\u00f1a\u00a0 en el camino para conseguir nuestro objetivo; mejorar el diagn\u00f3stico en ginecolog\u00eda, convirti\u00e9ndolo en un diagn\u00f3stico m\u00e1s accesible y menos invasivo para las mujeres\u201d, explica <b>Marina Rigau<\/b>, CEO y cofundadora de MiMARK Diagnostics. Rigau lidera la femtech junto con los co-fundadores <b>Antonio Gil-Moreno<\/b>, jefe del grupo de Investigaci\u00f3n Biom\u00e9dica en Ginecolog\u00eda del VHIR y jefe del servicio de Ginecolog\u00eda y Obstetricia en el Hospital Universitario Vall Hebron, y <b>Eva Col\u00e1s<\/b>, CSO de MiMARK e investigadora principal en el mismo grupo del VHIR.<\/p>\n<h3><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><b><span data-contrast=\"auto\">Transformar el diagn\u00f3stico ginecol\u00f3gico a trav\u00e9s de los fluidos ginecol\u00f3gicos<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/h3>\n<p>MiMARK Diagnostics tiene como misi\u00f3n transformar el diagn\u00f3stico ginecol\u00f3gico centr\u00e1ndose en el uso de fluidos ginecol\u00f3gicos como fuente de biomarcadores. \u201cLos fluidos ginecol\u00f3gicos nos permiten realizar un abordaje m\u00ednimamente invasivo para el diagn\u00f3stico de enfermedades ginecol\u00f3gicas con necesidades cl\u00ednicas no cubiertas, pues estos representan de forma muy espec\u00edfica a los tejidos colindantes de los \u00f3rganos ginecol\u00f3gicos\u201d, explica <b>Eva Col\u00e1s,<\/b> CSO de MiMARK.<\/p>\n<p>El primer producto de la compa\u00f1\u00eda y beneficiario de la inversi\u00f3n es WomEC, un test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio que se basa en el an\u00e1lisis de prote\u00ednas en la fracci\u00f3n soluble de una muestra de aspirado uterino. El c\u00e1ncer de endometrio es el primer c\u00e1ncer ginecol\u00f3gico en pa\u00edses desarrollados, con m\u00e1s de 6.700 nuevos\u202fcasos al a\u00f1o en Espa\u00f1a. El diagn\u00f3stico se inicia en mujeres que presentan un sangrado vaginal anormal, aunque solo 1 de cada 10 tendr\u00e1n un diagn\u00f3stico de c\u00e1ncer de endometrio. Hoy en d\u00eda el\u00a0diagn\u00f3stico requiere, en un n\u00famero elevado de mujeres, la realizaci\u00f3n de una biopsia guiada por histeroscopia, procedimiento invasivo que podr\u00eda ahorrarse con WomEC.<\/p>\n<p>\u201cCon la implementaci\u00f3n de WomEC ofreceremos a las pacientes un diagn\u00f3stico de c\u00e1ncer de endometrio menos invasivo y m\u00e1s preciso y r\u00e1pido, lo que permitir\u00e1 una mejora en la gesti\u00f3n de las pacientes con sospecha de c\u00e1ncer\u201d, subraya <b>Antonio Gil-Moreno<\/b>, cofundador de MiMARK, jefe del grupo de Investigaci\u00f3n Biom\u00e9dica en Ginecolog\u00eda del VHIR y jefe del servicio de Ginecolog\u00eda y Obstetricia en el Hospital Universitario Vall Hebron.<\/p>\n<p>\u201cMiMARK Diagnostics representa una gran oportunidad para mejorar el diagn\u00f3stico del c\u00e1ncer de endometrio, as\u00ed como el diagn\u00f3stico de otras patolog\u00edas como la endometriosis, para la que el diagn\u00f3stico actual es complejo y largo\u201d, destaca <b>Ignacio Prieto<\/b>, consejero de la compa\u00f1\u00eda por parte de Clave Capital. <b>Santiago Lozano<\/b>, director de fondos de Clave Capital, a\u00f1ade que esta nueva inversi\u00f3n est\u00e1 \u201cenfocada en valorizar resultados de la investigaci\u00f3n de centros que est\u00e1n haciendo una seria apuesta por la transferencia a mercado\u201d.<\/p>\n<p>\u00abLa inversi\u00f3n en MiMARK Diagnostics es un ejemplo perfecto de lo que queremos conseguir desde Nara Capital: apoyar en fases muy tempranas a empresas de centros de investigaci\u00f3n de alto rendimiento, con tecnolog\u00edas netamente disruptivas, con equipos humanos extraordinarios, y a los que podamos aportar, adem\u00e1s de capital, valor a\u00f1adido en conocimiento y acompa\u00f1amiento\u00bb, apunta por su parte <b>Joan Mercadal<\/b>, socio de Nara Capital, otro de los fondos que han liderado la operaci\u00f3n.<\/p>\n<p>Para <b>WA4STEAM<\/b>, asociaci\u00f3n de mujeres business angels que invierten y apoyan startups en \u00e1reas STEAM, en fases tempranas de desarrollo y lideradas por mujeres, \u201cla inversi\u00f3n en MIMARK Diagnostics encaja a la perfecci\u00f3n\u201d con los valores de la asociaci\u00f3n, \u201cdesde la perspectiva de liderazgo femenino, as\u00ed como de proyecto de base tecnol\u00f3gica con un claro impacto en la salud de la mujer\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MiMARK Diagnostics, spin-off del Vall d\u2019Hebron Instituto de Investigaci\u00f3n (VHIR) especializada en el desarrollo de soluciones innovadoras para el diagn\u00f3stico ginecol\u00f3gico con sede en el Parque Cient\u00edfico de Barcelona, ha&#8230;<\/p>\n","protected":false},"author":11,"featured_media":85394,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[345],"tags":[],"class_list":["post-85393","post","type-post","status-publish","format-standard","has-post-thumbnail","category-financiacion"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"MiMARK Diagnostics, spin-off del Vall d\u2019Hebron Instituto de Investigaci\u00f3n (VHIR) especializada en el desarrollo de soluciones innovadoras para el diagn\u00f3stico ginecol\u00f3gico con sede en el Parque Cient\u00edfico de Barcelona, ha...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-07T11:25:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Iuris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Iuris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/\"},\"author\":{\"name\":\"Iuris\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/2cac99ef7339e3499496b54bb2e12e7d\"},\"headline\":\"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio\",\"datePublished\":\"2023-06-07T11:25:31+00:00\",\"dateModified\":\"2025-10-13T13:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/\"},\"wordCount\":763,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/mimark.png\",\"articleSection\":[\"FINANCIACION\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/\",\"name\":\"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/mimark.png\",\"datePublished\":\"2023-06-07T11:25:31+00:00\",\"dateModified\":\"2025-10-13T13:03:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/2cac99ef7339e3499496b54bb2e12e7d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/mimark.png\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/mimark.png\",\"width\":900,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/2cac99ef7339e3499496b54bb2e12e7d\",\"name\":\"Iuris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g\",\"caption\":\"Iuris\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminiuris\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/","og_locale":"es_ES","og_type":"article","og_title":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona","og_description":"MiMARK Diagnostics, spin-off del Vall d\u2019Hebron Instituto de Investigaci\u00f3n (VHIR) especializada en el desarrollo de soluciones innovadoras para el diagn\u00f3stico ginecol\u00f3gico con sede en el Parque Cient\u00edfico de Barcelona, ha...","og_url":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2023-06-07T11:25:31+00:00","article_modified_time":"2025-10-13T13:03:51+00:00","og_image":[{"width":900,"height":300,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png","type":"image\/png"}],"author":"Iuris","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Iuris","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/"},"author":{"name":"Iuris","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/2cac99ef7339e3499496b54bb2e12e7d"},"headline":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio","datePublished":"2023-06-07T11:25:31+00:00","dateModified":"2025-10-13T13:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/"},"wordCount":763,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png","articleSection":["FINANCIACION"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/","url":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/","name":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png","datePublished":"2023-06-07T11:25:31+00:00","dateModified":"2025-10-13T13:03:51+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/2cac99ef7339e3499496b54bb2e12e7d"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/06\/mimark.png","width":900,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/mimark-diagnostics-capta-1-me-para-acelerar-el-desarrollo-de-su-test-de-diagnostico-in-vitro-para-cancer-de-endometrio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"MiMARK Diagnostics capta 1 M\u20ac para acelerar su test de diagn\u00f3stico in vitro para c\u00e1ncer de endometrio"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/2cac99ef7339e3499496b54bb2e12e7d","name":"Iuris","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a9d1bfedf501cbd8ae27b11de9986604bf4cdcea73b507457dfd4ff5dc770b75?s=96&d=mm&r=g","caption":"Iuris"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminiuris\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/85393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=85393"}],"version-history":[{"count":7,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/85393\/revisions"}],"predecessor-version":[{"id":87795,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/85393\/revisions\/87795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/85394"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=85393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=85393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=85393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}